Staff and Vice-Chair, Stem Cell Biology and Regenerative Medicine; Staff, Colorectal Surgery
Colon & Rectal Surgery
Dr. Emina H. Huang, MD
|
|
Give Review
Dr. Emina H. Huang works in the field of Colon & Rectal Surgery. She researched medicine at Stanford University School of Medicine. Stanford University School of Medicine is a top medical college. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine She received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Doctor Emina H. Huang, MD is a published MD. She has 48 publications published. The most current publication "Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit per..." Emina Huang accepts Medicare payments and is registered with Medicare.gov.
Publications
- CDX2: Linking Cell and Patient Fates in Colon Cancer.
- IL-22(+)CD4(+) T Cells Promote ColoRectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L.
- SSAT/ASCRS Joint Symposium: Controversies in Surgery for Ulcerative Colitis.
- The Colon Cancer Stem Cell Microenvironment Holds Keys to Future Cancer Therapy.
- TransAnal Excision with Radiation Therapy for Rectal Adenocarcinoma.
- Virus-derived anti-inflammatory proteins: potential therapeutics for Cancer.
- Can we develop effective combination antiangiogenic therapy for patients with hepatocellular Carcinoma?
- MOLECULAR BASIS OF HEREDITARY COLORectal CANCER.
- Atorvastatin induces apoptosis in vitro and slows growth of tumor xenografts but not polyp formation in MIN mice.
- Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to Cancer.
- Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.
- RAGE activation by S100P in colon Cancer stimulates growth, migration, and cell signaling pathways.
- A phase II study of preoperative capecitabine and radiation therapy in patients with Rectal cancer.
- Phenotypic characterization of human coloRectal cancer stem cells.
- Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance.
- Induction of inflammatory bowel Disease accelerates adenoma formation in Min +/- mice.
- Perioperative immunomodulation with Flt3 kinase ligand or a whole tumor cell vaccine is associated with a reduction in lung metastasis formation after laparotomy in mice.
- Safety and reliability of tattooing coloRectal neoplasms prior to laparoscopic resection.
- B cell response to tumor antigens is associated with depletion of B progenitors in murine coloCarcinoma.
- Plasma from patients undergoing major open surgery stimulates in vitro tumor growth: Lower insulin-like growth factor binding protein 3 levels may, in part, account fo...
- Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-...
- Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit per...
- The diagnostic and therapeutic roles of colonoscopy: a review.
- A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in Cancer.
- Quantification of beta-catenin signaling components in colon Cancer cell lines, tissue sections, and microdissected tumor cells using reaction monitoring mass spectrom...
- Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel Disease.
- The percentage of CD31+ T cells decreases after open but not laparoscopic surgery.
- IL-17+ regulatory T cells in the microenvironments of chronic inflammation and Cancer.
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.
- Surgical implications of colonoscopy.
- Time course of differences in lymphocyte proliferation rates after laparotomy vs CO(2) insufflation.
- CDX2 does not suppress tumorigenicity in the human gastric Cancer cell line MKN45.
- FOXP3 defines regulatory T cells in human tumor and autoimmune Disease.
- Human colon Cancer stem cells: a new paradigm in gastrointestinal oncology.
- A serum-soluble factor(s) stimulates tumor growth following laparotomy in a murine model.
- Laparoscopic-assisted cecectomy is associated with decreased formation of postoperative pulmonary metastases compared with open cecectomy in a murine model.
- Lymphocyte proliferation in mice after a full laparotomy is the same whether performed in a sealed carbon dioxide chamber or in room air.
- Colonoscopy in mice.
- Increased incidence of coloRectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps.
- Review paper: Implications of the "Cancer stem cell" hypothesis on murine models of colon Cancer and colitis-associated Cancer.
- Hybrid laparoscopic flexure takedown and open procedure for Rectal resection is associated with significantly shorter length of stay than equivalent open resection.
- Increased platelet-derived growth factor (PDGF) release after laparotomy stimulates systemic tumor growth in mice.
- Significant reduction of laparotomy-associated lung metastases and subcutaneous Tumors after perioperative immunomodulation with flt3 ligand in mice.
- Is there a role for a strict incision length criterion for determining conversions during laparoscopic coloRectal resection?
- CEA-based vaccines.
- RAGE and RAGE ligands in Cancer.
- Colon Cancer stem cells: implications for prevention and therapy.
Schools
Stanford University School Of Medicine
Ohio State University
Grant Med Center
Procedures Preformed
- Anoscopy With Removal of Anal Tumor
- Colectomy
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Destruction of Anal Tumor
- View All
Conditions Treated
- Anal and Rectal Cancer
- Anal Fissure
- Anal Fistula
- AnoRectal Abscess
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Ohio State University Hospital -
Stanford University School of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1093815839 | |
| NPPES Provider LastName | HUANG | |
| NPPES Provider FirstName | EMINA | |
| NPPES Provider ZIPCode | 326103003 | |
| NPPES Provider State | FL | |
| Specialty Description | Colorectal Surgery (formerly proctology) | |
| Total Claim Count | 18.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093815839 |
| Last Name Of The Provider | HUANG |
| First Name Of The Provider | EMINA |
| View All |
Similar Doctors
|
|
Dr. Salvatore T. Scali, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanda A. Tan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brendan J. Boland, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alexander J. Rim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tyler J. Loftus, MD |
|
|
Dr. Trevan D. Fischer, MD |
|
|
Dr. Kyle M. Staton, MD |
|
|
Dr. Geoffrey J. Roelant, MD
This Doctor is OpenDoctor Recommended.
|